<DOC>
	<DOCNO>NCT01248104</DOCNO>
	<brief_summary>We hypothesize tranexamic acid administration associate 25 % improvement volume blood loss red blood cell ( RBC ) administration , increase decrease perioperative complication</brief_summary>
	<brief_title>Comparison Tranexamic Epsilon Aminocaproic Acid : Prospective Analysis Blood Conservation Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Aminocaproic Acid</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>1 . Is subject 18 year age old ? 2 . Is subject scheduled primary cardiac surgery utilize cardiopulmonary bypass ( CPB ) ? 3 . Is subject 30 kg ( 66 lb ) ? 4 . Does subject understand English ? 1 . Does subject exist coagulation defect ( INR &gt; 1.5 , platelet &lt; 100 ? 2 . Does subject renal failure ( define BUN/Cr ratio 20:1 ? 3 . Does subject severe liver disease ( AST &amp; ALT &gt; 3x normal ) ? 4 . Is subject emergency cardiac surgery , complex aortic surgery , combination valve/CABG surgery , redo cardiac surgery ? 5 . Is subject procedure CPB anticipate ? 6 . Is patient weight great 150 kg ?</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Cardiac Surgery</keyword>
	<keyword>Antifibrinolytic agent</keyword>
	<keyword>Blood transfusion</keyword>
	<keyword>epsilon aminocaproic acid</keyword>
	<keyword>tranexamic acid</keyword>
</DOC>